NCT03579732View on ClinicalTrials.gov

EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan

CompletedOBSERVATIONAL

Enrollment

4,710,504

Participants

Timeline

Start Date

June 29, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions

Colorectal Neoplasms

Interventions

DRUG

Aspirin (Acetylsalicylic Acid, BAYE4465)

Low dose of aspirin, i.e. \< 150 mg daily

OTHER

No drug

Non-consumers

Trial Locations (1)

100

National University of Taiwan Hospital, Taipei

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT03579732 - EffectiveNess of Low Dose Aspirin in GastrointEstinal Cancer Prevention - Taiwan | Biotech Hunter | Biotech Hunter